These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18503154)

  • 1. Different behaviour of soluble CD40L concentrations can be reflected by variations of preanalytical conditions.
    Wenzel F; Baertl A; Zimmermann N; Hohlfeld T; Giers G; Oldenburg J; Assert R
    Clin Hemorheol Microcirc; 2008; 39(1-4):417-22. PubMed ID: 18503154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pre-analytical and analytical factors on soluble CD40L measurements.
    Varo N; Nuzzo R; Natal C; Libby P; Schönbeck U
    Clin Sci (Lond); 2006 Nov; 111(5):341-7. PubMed ID: 16856875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sample type on soluble CD40 ligand assessment in patients with acute coronary syndromes.
    Weber M; Rabenau B; Stanisch M; Nef HM; Möllmann H; Elsässer A; Mitrovic V; Heeschen C; Hamm C
    Thromb Res; 2007; 120(6):811-4. PubMed ID: 17337289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk.
    Ahn ER; Lander G; Jy W; Bidot CJ; Jimenez JJ; Horstman LL; Ahn YS
    Thromb Res; 2004; 114(2):143-8. PubMed ID: 15306157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
    Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
    Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates.
    Wenzel F; Günther W; Baertl A; Lasshofer R; Rox J; Fischer JC; Giers G
    Clin Hemorheol Microcirc; 2011; 47(4):269-78. PubMed ID: 21654056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
    Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
    Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
    Ludwiczek O; Kaser A; Tilg H
    Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
    Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
    Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
    Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L.
    Fan Y; Ge Y; Zhu H; Wang Y; Yang B; Zhuang Y; Ma H; Zhang X
    Tissue Antigens; 2004 Sep; 64(3):257-63. PubMed ID: 15304006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L.
    Nagasawa M; Zhu Y; Isoda T; Tomizawa D; Itoh S; Kajiwara M; Morio T; Nonoyama S; Shimizu N; Mizutani S
    Eur J Haematol; 2005 Jan; 74(1):54-60. PubMed ID: 15613107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of thromboxane formation, soluble CD40L release and thrombopoietin clearance in apheresis platelet concentrates.
    Wenzel F; Baertl A; Hohlfeld T; Zimmermann N; Weber AA; Lorenz H; Giers G
    Platelets; 2012; 23(2):150-6. PubMed ID: 21806498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
    Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
    Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure.
    Yan JC; Liu PJ; Du RZ; Liang Y; Ma GS; Zhu J; Luo D
    Clin Chim Acta; 2008 Jun; 392(1-2):17-20. PubMed ID: 18339317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia.
    Wenzel F; Günther W; Baertl A; Gruber W; Sorg RV; Haas R; Giers G
    Transfusion; 2012 Jun; 52(6):1213-20. PubMed ID: 22082313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
    Chung I; Choudhury A; Patel J; Lip GY
    J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.